27.56
0.15 (0.55%)
Previous Close | 27.41 |
Open | 27.42 |
Volume | 305,507 |
Avg. Volume (3M) | 898,392 |
Market Cap | 13,239,933,952 |
Price / Earnings (TTM) | 25.76 |
Price / Earnings (Forward) | 25.97 |
Price / Sales | 1.47 |
Price / Book | 1.67 |
52 Weeks Range | |
Earnings Date | 20 Feb 2025 |
TTM Dividend Yield | 3.85% |
Profit Margin | 5.70% |
Operating Margin (TTM) | 10.69% |
Diluted EPS (TTM) | 1.07 |
Quarterly Revenue Growth (YOY) | 14.10% |
Quarterly Earnings Growth (YOY) | 2.00% |
Total Debt/Equity (MRQ) | 55.92% |
Current Ratio (MRQ) | 1.01 |
Operating Cash Flow (TTM) | 1.07 B |
Levered Free Cash Flow (TTM) | 427.14 M |
Return on Assets (TTM) | 3.88% |
Return on Equity (TTM) | 6.80% |
Market Trend
Short Term | Medium Term | ||
Industry | Diagnostics & Research (AU) | Mixed | Mixed |
Diagnostics & Research (Global) | Mixed | Mixed | |
Stock | SONIC HLTH FPO [SHL] | - | - |
AIStockmoo Score
Analyst Consensus | 0.0 |
Insider Activity | NA |
Price Volatility | -1.0 |
Technical Moving Averages | 1.0 |
Technical Oscillators | 5.0 |
Average | 1.25 |
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand, and the third largest in the US. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 40% of group revenue in Australia and New Zealand, 25% in the US, and 35% in Europe. |
|
Sector | Healthcare |
Industry | Diagnostics & Research |
Investment Style | Large Core |
% Held by Insiders | 5.37% |
% Held by Institutions | 42.46% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |